SERPINE1 and metabolic dysfunction-associated steatohepatitis: Indeed, while active PAI-1 levels were shown to be related to severe stages of the disease, e.g., manifest steatosis or NASH [43], this acute-phase protein was also shown to be related to HOMA-IR by others [44], and it was similarly higher in both overweight groups in the present study when compared to controls.